Table I.
Baseline characteristics of the study subjects (N = 22). (Values are expressed as mean [SD] unless otherwise specified.)
| Characteristic | Treatment Group (n = 11) | Placebo Group (n = 11) |
|---|---|---|
| Age, y | 35.4 (8.6) | 38.5 (7.9) |
| Sex, no. (%) of subjects | ||
| Women | 7 (63.6) | 8 (72.7) |
| Men | 4 (36.4) | 3 (27.3) |
| Body weight, kg | 101.0 (20.8) | 91.6 (16.8) |
| Body fat, % | 39.4 (10.3) | 40.0 (5.9) |
| Absolute fat mass, kg | 40.2 (16.1) | 36.4 (7.6) |
| LBM, kg | 60.8 (15.2) | 55.2 (13.1) |
| BMI, kg/m2 | 36.8 (7.7) | 34.6 (4.4) |
| UAC, cm | 106.4 (11.7) | 100.0 (10.9) |
| WC, cm | 111.8 (15.3) | 103.5 (13) |
| HC, cm | 125.3 (14.6) | 120.3 (6.3) |
LBM = lean body mass; BMI = body mass index; UAC = upper abdominal circumference; WC = waist circumference; HC = hip circumference.